Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome

Stroke

Volumn 44, Issue 8, 2013, Pages 2321-2323

  Boehme, Amelia K ^a,b   Kapoor, Niren ^a   Albright, Karen C ^a,b,c   Lyerly, Michael J ^a   Rawal, Pawan V ^a   Shahripour, Reza Bavarsad ^a   Alvi, Muhammad ^a   Houston, J Thomas ^a   Sisson, April ^a   Beasley, T Mark ^b   Alexandrov, Anne W ^a,b   Alexandrov, Andrei V ^a   Miller, David W ^d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

inflammation; ischemic stroke; stroke care; tPA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BODY TEMPERATURE; BREATHING RATE; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HEART RATE; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANKIN SCALE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

INFLAMMATION; ISCHEMIC STROKE; STROKE CARE; TPA;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880794608     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001371     Document Type: Article

References (13)

1. American college of Chest Physicians/Society of Critical Care Medicine consensus conference: defnitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
2. Danton GH, Dietrich WD. Infammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol. 2003;62:127-136.
3. Lindsberg PJ, Grau AJ. Infammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532. (Pubitemid 37221976)
4. D'Ambrosio AL, Pinsky DJ, Connolly ES. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol Med. 2001;7:367-382. (Pubitemid 33701972)
5. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE. Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol. 2004;137:117-122. (Pubitemid 38869785)
6. Audebert HJ, Rott MM, Eck T, Haberl RL. Systemic infammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke. 2004;35:2128-2133. (Pubitemid 39129573)
7. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic infammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32:1989-1993. (Pubitemid 32868085)
8. Wartenberg KE, Stoll A, Funk A, Meyer A, Schmidt JM, Berrouschot J. Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat. 2011;2011:830614.
9. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YJ, et al. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 2008;15:1324-1331.
10. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620-625. (Pubitemid 36246079)
11. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, et al. Medical complications after stroke: a multicenter study. Stroke. 2000;31:1223-1229. (Pubitemid 30351237)
12. Boysen G, Christensen H. Stroke severity determines body temperature in acute stroke. Stroke. 2001;32:413-417. (Pubitemid 32155227)
13. Kumar AD, Boehme AK, Siegler JE, Gillette M, Albright KC, Martin-Schild S. Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. J StrokeCerebrovasc Dis. 2012.